5 December 2019 - Epilepsy patients are upset about a PHARMAC funded video which they say downplays the side effects of a drug that's been linked to four unexplained deaths.
PHARMAC has backtracked on its decision to make Logem the only funded anti-epileptic drug available.
Epilepsy patient Jack Anderson's health began deteriorating rapidly in August, unaware that his epilepsy medication had changed to Logem in a PHARMAC brand switch.